A carregar...
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
Atypical hemolytic-uremic syndrome (aHUS) is associated with genetic complement abnormalities/anti–complement factor H antibodies, which paved the way to treatment with eculizumab. We studied 44 aHUS patients and their relatives to (1) test new assays of complement activation, (2) verify whether suc...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4162105/ https://ncbi.nlm.nih.gov/pubmed/25037630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-02-558296 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|